Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Leerink Partners Global Biopharma Conference March 13, 2024 10:40 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations Christopher Fenimore - Chief Financial Officer Conference Call Participants David Risinger - Leerink Partners David Risinger Thanks very much for being with us here today. I thought we could just start with the EYLEA franchise. Okay. We'll just jump right into it. Ryan Crowe Actually, David, if I could just read a forward-l ...